TY - JOUR
KW - Adolescent
KW - Adult
KW - Attention Deficit Disorder with Hyperactivity/drug therapy
KW - Central Nervous System Stimulants/administration & dosage/adverse effects
KW - Double-Blind Method
KW - Drug Administration Schedule
KW - Drug-Related Side Effects and Adverse Reactions/drug therapy
KW - Euphoria/drug effects
KW - Female
KW - Humans
KW - Male
KW - Methylphenidate/administration & dosage/adverse effects
KW - Naltrexone/administration & dosage/pharmacology
KW - Narcotic Antagonists/administration & dosage/pharmacology
KW - Treatment Outcome
KW - Young Adult
AU - T. J. Spencer
AU - P. Bhide
AU - J. Zhu
AU - S. V. Faraone
AU - M. Fitzgerald
AU - A. M. Yule
AU - M. Uchida
AU - A. E. Spencer
AU - A. M. Hall
AU - A. J. Koster
AU - L. Feinberg
AU - S. Kassabian
AU - B. Storch
AU - J. Biederman
A1 - 
AD - Massachusetts General Hospital, 55 Fruit St, Warren 705, Boston, MA 02144. spencer@helix.mgh.harvard.edu.; Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.; Department of Neuroscience, Florida State University, Tallahassee, Florida, USA.; Department of Neuroscience, Florida State University, Tallahassee, Florida, USA.; Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, New York, USA.; K. G. Jebsen Centre for Psychiatric Disorders, Department of Biomedicine, University of Bergen, Bergen, Norway.; Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts, USA.; Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.; Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.; Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.; Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts, USA.; Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts, USA.; Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts, USA.; Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts, USA.; Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts, USA.; Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of (TRUNCATED)
BT - The Journal of clinical psychiatry
C5 - Healthcare Disparities; Measures; Opioids & Substance Use
CP - 2
DO - 10.4088/JCP.17m11609
IS - 2
JF - The Journal of clinical psychiatry
LA - eng
M1 - Journal Article
PB - Physicians Postgraduate Press, Inc
PY - 2018
SN - 1555-2101; 0160-6689; 0160-6689
SP - 17m11609. doi: 10.4088/JCP.17m11609
T1 - The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone
T2 - The Journal of clinical psychiatry
TI - The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone
U1 - Healthcare Disparities; Measures; Opioids & Substance Use
U2 - 29617066
U3 - 10.4088/JCP.17m11609
VL - 79
VO - 1555-2101; 0160-6689; 0160-6689
Y1 - 2018
Y2 - Mar/Apr
ER -